DUPIXENT Health Economics and Value Assessment Business Partner VIE

DUPIXENT Health Economics and Value Assessment Business Partner - VIE Contract

• Location:
  
  United States of America, Cambridge
• Target start date: 01/01/2027

iMove, the Sanofi VIE Program, is available to citizens of the European Economic Area (EU + Norway, Liechtenstein and Iceland) aged between 18 and 28.

About the job

As DUPIXENT Health Economics and Value Assessment Business Partner VIE within our Market Access team, you will contribute significantly, both in quantity and quality, to scientific work that the HEVA (Health Economics and Value Assessment) Respiratory/Rhinology/GI team delivers.
DUPIXENT is the flagship of the Sanofi Specialty Care life changing Immunology Franchise. It is currently being launched worldwide for conditions including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis and prurigo nodularis, with the ambition of becoming the treatment of choice for all type 2 inflammation diseases due to its innovative mode of action. The portfolio for this product includes 10+ indications currently being evaluated at various stages of clinical development.

Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs.

Ready to get started?

We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.

• Manage and execute health economics and outcomes research (HEOR) studies to support the clinical, economic, and humanistic value propositions of dupilumab across respiratory, rhinology and GI indications. Such studies may include core value dossier/ Academy of Managed Care Pharmacy (AMCP) dossier, burden of illness, epidemiology, literature review, real-world evidence, meta-analysis, economic models, and patient-reported outcomes.
• Support contracting and project management activities.
• Set evidence generation priorities and direction for assigned responsibilities and incorporate them into daily practice.
• Support the Integrated Evidence Generation Plan and Brand Planning processes, supervised by HEVA Business Partners.
• Develop and maintain collegial relationships with internal cross-functional global/US stakeholders and external alliance partners.

• At least 1 year of previous experience in connection with this field.
• Previous experience in Health Economics and Outcomes Research or Health Services Research would be a plus.
• Solid experience with HEOR methodologies and applications is appreciated.

• Effective communication skills, both written and verbal, including presentation skills.
• Agility and flexibility to adapt to ways of working within the organization.
• Strong ability to partner with colleagues from other functional areas (Market Access & Pricing, Medical Affairs, Commercial).
• Knowledge of and experience with Global Health Technology Assessment (HTA), processes and guidelines, submissions preferred.
• Proficiency in principles of evidence-based medicine and clinical research.

• Master’s degree in Health Economics and Outcomes Research (HEOR)-related scientific disciplines or similar field.

• Fluent English (written and verbal).

• Be part of a pioneering biopharma company where patient insights shape drug development.
• Work at the forefront of AI-powered science that accelerates…